Business | Sunday June 9, 2013
The Drug Controller General of India (DGCI) DGCI is conducting a "focussed scrutiny" of medicines sold by Ranbaxy and some other drug makers. The drug regulator has, however, said that it remains confident of the quality standards of Indian medicines despite concerns raised by US authorities over some of Ranbaxy's products.
www.ndtv.com/business